[Federal Register: September 8, 2006 (Volume 71, Number 174)]
[Notices]               
[Page 53134]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08se06-73]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division

 
Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Sequence VID Test Development Consortium

    Notice is hereby given that, on August 4, 2006, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Sequence VID Test Development 
Consortium has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing (1) The 
identities of the parties to the venture and (2) the nature and 
objectives of the venture. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances.
    Pursuant to Section 6(b) of the Act, the identities of the parties 
to the venture are: American Petroleum Institute, Washington, DC; 
General Motors Corp., Warren, MI; Chevron Products Co., Richmond, CA; 
Ford Motor Company, Dearborn, MI; Lubrizol Corporation, Wickliffe, OH; 
Chevron Oronite Company LLC, Richmond, CA; Shell Oil Company, Houston, 
TX; ExxonMobil Research & Engineering Corporation, Paulsboro, NJ; 
Infineum International, Ltd., Linden, NJ; Afton Chemical Corporation, 
Richmond, VA; and R.T. Vanderbilt Co., Inc., Norwalk, CT. The general 
area of Sequence VID Test Development Consortium's planned activity is 
to develop an engine dynamometer-based fuel economy test for ILSAC GF-5 
that will represent the viscometric and friction modifier oil effects 
on the fuel economy of current and future North American and Japanese 
engines.

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 06-7519 Filed 9-7-06; 8:45 am]

BILLING CODE 4410-11-M